Maternal and Neonatal Health

Publications

click to view chapters and sections

Disease Control Priorities in Developing Countries (2nd Edition)
  1. 1. Investing in Health
    1. The Economic Benefits of Better Health
    2. Child Health
  2. 2. Intervention Cost–Effectiveness: Overview of Main Messages
    1. Assessing the Evidence on the Cost-Effectiveness of Interventions
  3. 3. Strengthening Health Systems
  4. 4. Priorities for Global Research and Development of Interventions
    1. Needs, Context, Opportunities, and Major Challenges
  5. 5. Science and Technology for Disease Control: Past, Present, and Future
    1. Science, Technology, and Medicine in the 20th Century
    2. Science, Technology, and Medicine in the Future
  6. 8. Improving the Health of Populations: Lessons of Experience
    1. Cases
    2. Intervention Type, Programmatic Characteristics, and Policies
  7. 9. Millennium Development Goals for Health: What Will It Take to Accelerate Progress?
    1. Scaling Up: Defining Interventions and Removing Constraints
    2. What Do Countries Need To Do?
  8. 10. Gender Differentials in Health
    1. Antecedents
    2. Priority Disease Groups for Women
    3. Cost-Effectiveness of Interventions
  9. 11. Fiscal Policies for Health Promotion and Disease Prevention
  10. 13. Recent Trends and Innovations in Development Assistance for Health
    1. Trends and Gaps in Development Assistance for Health
    2. Recent Innovations to Improve the Effectiveness of Development Assistance for Health
  11. 15. Cost–Effectiveness Analysis for Priority Setting
    1. Definition and Characteristics of Interventions
  12. 16. Tuberculosis
  13. 17. Sexually Transmitted Infections
    1. Introduction
    2. Bacterial and Viral STIs and Their Sequelae
    3. Effectiveness of the Principal Interventions
  14. 18. HIV/AIDS Prevention and Treatment
    1. Action under Uncertainty
    2. Prevention in Theory and Practice: Using Epidemic Profiles and Contextual Factors to Inform Prevention Guidelines
  15. 19. Diarrheal Diseases
    1. Public Health Significance of Diarrheal Illnesses
    2. Preventive Strategies
  16. 20. Vaccine–Preventable Diseases
    1. Causes and Epidemiology of Diseases Prevented by Vaccines Used in National Immunization Programs
  17. 21. Conquering Malaria
    1. Burden of Disease
    2. Interventions and Their Effectiveness
    3. Economics of Malaria Control Interventions
  18. 24. Helminth Infections: Soil–Transmitted Helminth Infections and Schistosomiasis
    1. Cost-Effectiveness Analysis of Interventions
  19. 25. Acute Respiratory Infections in Children
    1. Causes of ARIs and the Burden of Disease
    2. Interventions
    3. Implementation of ARI Control Strategies: Lessons of Experience
  20. 26. Maternal and Perinatal Conditions
    1. Epidemiology of Maternal and Perinatal Conditions
    2. Interventions
    3. Cost-Effectiveness of Selected Intervention Packages
    4. Economic Benefits of Intervention
    5. Lessons for Implementation
    6. Research and Development Needs
    7. Conclusions
    8. Annex 26.A: CEA Model Assumptions
    9. Acknowledgments
  21. 27. Newborn Survival
    1. Neonatal Deaths
    2. Interventions
    3. Marginal Impact and Cost of Scaling Up Universal Neonatal Packages
    4. Implementation
    5. Research Priorities
    6. Conclusions
    7. Acknowledgments
  22. 28. Stunting, Wasting, and Micronutrient Deficiency Disorders
    1. Interventions
  23. 30. Diabetes: The Pandemic and Potential Solutions
  24. 32. Neurological Disorders
    1. Epilepsy
  25. 34. Inherited Disorders of Hemoglobin
    1. Introduction
    2. Burden of Disease
    3. Control and Treatment
    4. Costs and Effectiveness of Diagnosis and Management
    5. Options for Control and Management of Inherited Hemoglobin Disorders
  26. 36. Diseases of the Kidney and the Urinary System
  27. 38. Oral and Craniofacial Diseases and Disorders
    1. Developmental Disorders
  28. 42. Indoor Air Pollution
  29. 43. Air and Water Pollution: Burden and Strategies for Control
  30. 47. Alcohol
  31. 48. Illicit Opiate Abuse
    1. Annex 48.A: Prevalence of Use, Adverse Health Effects of and Interventions for Cannabis, Cocaine, Amphetamines, and MDMA Use and Dependence
  32. 49. Learning and Developmental Disabilities
    1. Interventions in Low- and Middle-Income Countries
    2. Research Agenda for Prevention of Disabilities in Low- and Middle-Income Countries
    3. Summary
  33. 50. Loss of Vision and Hearing
    1. Nature, Causes, and Epidemiology of Hearing Loss
  34. 56. Community Health and Nutrition Programs
    1. Community-Based Programs—What Are They?
  35. 57. Contraception
    1. Nature, Causes, and Burden of the Conditions That Can Be Addressed
    2. Interventions
    3. Intervention Cost and Cost-Effectiveness
    4. Research and Development Agenda
  36. 62. Control and Eradication
  37. 63. Integrated Management of the Sick Child
  38. 64. General Primary Care
  39. 65. The District Hospital
  40. 68. Emergency Medical Services
    1. Interventions for Emergency Care: Systems, Structures, and Organization
    2. Definitions
  41. 71. Health Workers: Building and Motivating the Workforce
Global Burden of Disease and Risk Factors
  1. 1. Measuring the Global Burden of Disease and Risk Factors, 1990—2001
    1. Major Findings of the 2001 GBD Study
  2. 3. The Burden of Disease and Mortality by Condition: Data, Methods, and Results for 2001
    1. Estimating Deaths by Cause: Methods and Data
    2. Global and Regional Mortality in 2001
    3. Estimating Incidence, Prevalence, and YLD: Methods and Data
  3. 4. Comparative Quantification of Mortality and Burden of Disease Attributable to Selected Risk Factors
    1. Burden of Disease Attributable to Individual Risk Factors
  4. 5. Sensitivity and Uncertainty Analyses for Burden of Disease and Risk Factor Estimates
    1. Sensitivity of Burden of Disease and Injury Results to Variations in Key Parameter Values
  5. 6. Incorporating Deaths Near the Time of Birth into Estimates of the Global Burden of Disease
    1. Stillbirths and Neonatal Mortality in the Context of the Global Burden Of Disease
    2. The Burden of Disease Resulting from Events Near the Time of Birth
    3. Conclusions
    4. Annex 6A: Flexible Functional Forms for the Acquisition of Life Potential
    5. Annex 6C: Causes of Neonatal Mortality: Comparison of Numbers from the Global Burden of Disease with those from the Child Health Epidemiology Reference Group
    6. Acknowledgments
Priorities in Health
  1. 1. Accomplishments, Challenges, and Priorities
    1. Accounting for Health Gains
    2. Equity
  2. 2. Success in Addressing Priorities
    1. Cost-Effective Interventions Aimed at Building Health Systems
    2. Cost-Effective Interventions That Furthered Existing Health Systems
  3. 3. Cost–Effectiveness Analysis
  4. 4. Cost–Effective Strategies for the Excess Burden of Disease in Developing Countries
    1. Infectious and Communicable Diseases
    2. Maternal and Neonatal Health
  5. 5. Cost–Effective Strategies for Noncommunicable Diseases, Risk Factors, and Behaviors
    1. Congenital and Developmental Disorders
  6. 6. Providing Interventions
    1. Levels of Care
    2. Integration of Services Across the Life Cycle
  7. 7. Pillars of the Health System
  8. 8. The Way Forward: A Blueprint for Action

Resources

Related Analysis
  1. Analyzing Health Equity Using Household Survey Data: A guide to techniques and their implementation (PDF | 3.3MB)
  2. At Least One-Third of Poor Countries - Disease Burden Is Due To Malnutrition (PDF | 4.3MB)
  3. Bellagio Report - Conference on Increasing Access to Surgical Services in Resource-Constrained Settings in Sub-Saharan Africa (PDF | 60.7k)
  4. Curbing tobacco use in Poland
  5. Deaths and Disease Burden by Cause: Global Burden of Disease Estimates for 2001 by World Bank Country Groups (PDF | 1.7MB)
  6. Disease and Mortality in Sub-Saharan Africa, Second Edition (PDF | 5.1MB)
  7. Eliminating measles in southern Africa
  8. Feasibility of Scaling-up Interventions: The Role of Intervention Design (PDF | 744.1k)
  9. Fertility Regulation Behaviors and Their Costs: Contraception and Unintended Pregnancies in Africa and Eastern Europe & Central Asia (PDF | 2.6MB)
  10. Improving the health of the poor in Mexico
  11. Investing in Global Health "Best Buys" and Priorities for Action in Developing Countries (PPT | 463.5k)
  12. New Perspectives on the Causes and Potential Costs of Malaria: The Growth and Development of Children. What Should We be Measuring and How Should We be Measuring It? (PDF | 1.8MB)
  13. Preventing diarrheal deaths in Egypt
  14. Preventing Hib disease in Chile and The Gambia.
  15. Progress in the Development of a Recombinant Vaccine for Human Hookworm Disease: The Human Hookworm Vaccine Initiative (PDF | 403.6k)
  16. Reducing fertility in Bangladesh
  17. Saving mothers' lives in Sri Lanka
  18. Science and Technology for Disease Control: Past, Present, and Future (PDF | 280.5k)
  19. Soil Transmitted Helminth Infections: The Nature, Causes and Burden of the Condition (PDF | 3.6MB)
  20. The Cost-Effectiveness of Primary Care Services in Developing Countries: A Review of the International Literature (PDF | 382.2k)
  21. The Implications of Technology Change for Health Care Delivery in Sri Lanka (PDF | 188.0k)
  22. The Public Health Burden of Plasmodium falciparum Malaria in Africa: Deriving the Numbers (PDF | 5.9MB)
  23. Undernutrition as an underlying cause of malaria morbidity and mortality (PDF | 340.7k)
  24. Unit Costs of Health Care Inputs in Low and Middle Income Regions (PDF | 1.2MB)
  25. Water Supply, Sanitation, and Hygiene Promotion (PDF | 506.3k)
  26. Why Has Infant Mortality Decreased at Such Different Rates in Different Countries? (PDF | 413.5k)
  27. World Development Report 1993: Investing in Health (PDF | 6.1MB)
 

Back to Full List of Topics

QUICK FIND

Find specific content in the three core DCPP publications.




EMAIL UPDATES

Sign up to receive periodic email updates from DCPP